CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of...
MENLO PARK, Calif.--(BUSINESS WIRE)--Avellino Lab USA, Inc. (Avellino) today announced the appointment of Dr. Elizabeth Yeu to the company’s Board of Directors. Dr. Yeu...
SAN DIEGO--(BUSINESS WIRE)--Escient Pharmaceuticals, a clinical-stage company focused on discovering and developing novel, first-in-class therapies to address serious, unserved medical needs, today announced the...
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the...
SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant...
BOULDER, Colo.--(BUSINESS WIRE)--Inscripta, Inc., The Digital Genome Engineering Company, today announced that it has appointed Kristala Prather, PhD, to serve on its Board of...
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
